Name | Type | Posted | Actions |
|---|---|---|---|
combined synopsis-solicitation 134405 plate reader.pdf | Jun 12, 2026 |
Cytation 9 multimode reader or equal instrument
Contact and place of performance
Nick Sartain
Silver Spring, MD 20993
USA
See attached combined synopsis/solicitation.
The Food and Drug Administration (FDA) is seeking a Cytation 9 multimode plate reader or an equivalent instrument to support the Laboratory of Mucosal Pathogens and Cellular Immunology. This system must perform absorbance, fluorescence, and luminescence detection. The acquisition is being conducted as a Request for Quote (RFQ) under solicitation number 75F40126Q134405. Performance will take place in Silver Spring, Maryland, with a required delivery timeline of 60 days from the date of award. Evaluation is based on the Lowest Price Technically Acceptable (LPTA) process, and technical quotes must demonstrate how the proposed instrument meets all salient characteristics in the Statement of Work. Submissions are due by June 18, 2026. This procurement is for a multimode reader capable of absorbance, fluorescence, and luminescence detection. The FDA requires a new multimode plate reader to replace an end-of-life Cytation 3 unit at the Laboratory of Mucosal Pathogens and Cellular Immunology (LMPCI).
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.